Please login to the form below
IDT Biologika
This page shows the latest IDT Biologika news and features for those working in and with pharma, biotech and healthcare.
AZ partners with IDT Biologika to bolster manufacturing for COVID-19 vaccine in EU
AZ is looking to accelerate vaccine output in Q2 2021. AstraZeneca (AZ) has linked up with IDT Biologika to increase manufacturing of its Oxford University-partnered COVID-19 vaccine in the ... We are delighted to be investing with our partner IDT
Latest news
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest Intelligence
-
FlyPharma Europe unites pharma, biotech and bio pharma with air cargo logistics
IDT Biologika, a global contract manufacturer of vaccines and active ingredients based in Dessau, also in Saxony-Anhalt, partnered with AstraZeneca and Johnson &Johnson to fill millions of vials with their ... Maria Lahtinen, VP Operations, Faron
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Roche’s Polivy recommended by NICE for lymphoma therapy
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- AbbVie’s Rinvoq approved by MHRA for Crohn's disease
- GSK’s Benlysta given orphan drug status by FDA for systemic sclerosis
- Gilead’s Trodelvy approved by FDA for metastatic breast cancer
- World Health Organization releases new road map for breast cancer
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- Making new year resolutions that can also benefit others
- AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer
- ICR calls for improved biomarker cancer tests to help personalise treatment
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Bristol Myers Squibb’s plaque psoriasis treatment recommended by CHMP
- Europe’s cancer community publishes new report on transforming patient care
- Pre-launch planning and DSLs – the new ways to create launch excellence in pharma
- The Chronicles of Pharma: a creative review of pharma’s journey to omnichannel
- Boehringer reports positive phase 2 data for spesolimab in generalised pustular psoriasis
PMHub
Hanover Communications
Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...
Latest intelligence
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
- Pharmaceutical Marketing Strategies For The Digital Age
- In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...
